EDITORIAL: What's in store at MHRA under NICE man Rawlins?
This article was originally published in Scrip
The appointment of Professor Sir Michael Rawlins as chair of the UK Medicines and Healthcare Products Regulatory Agency will capture the attention of anyone with even a passing interest in the future of drug and medical device regulation.
You may also be interested in...
Change in leadership at the European Medicines Agency comes at a critical time.
The change in leadership at the European Medicines Agency comes at a critical time.
Another three marketing authorization applications will be fast-tracked through the centralized review process at the European Medicines Agency. The Pink Sheet tracker logs these and other developments relating to the agency's accelerated assessment mechanism.